Expression of mutant human epidermal receptor 3 attenuates lung fibrosis and improves survival in mice
Authors:
- Bethany B. MooreBMBethany B. Moore
- George MinowadaGMGeorge Minowada
- James CarrollJCJames Carroll
- Jihane A. FaressJFJihane A. Faress
- Jeffrey A. KernJKJeffrey A. Kern
- 1 July 2005
- journal article
- Published by American Physiological Society in Journal of Applied Physiology
- Vol. 99 (1) , 298-307
Abstract
Neuregulin-1 (NRG-1), binding to the human epidermal growth factor receptor HER2/HER3, plays a role in pulmonary epithelial cell proliferation and recovery from injury in vitro. We hypothesized that activation of HER2/HER3 by NRG-1 would also play a role in recovery from in vivo lung injury. We tested this hypothesis using bleomycin lung injury of transgenic mice incapable of signaling through HER2/HER3 due to lung-specific dominant-negative HER3 (DNHER3) expression. In animals expressing DNHER3, protein leak, cell infiltration, and NRG-1 levels in bronchoalveolar lavage fluid increased after injury, similar to that in nontransgenic littermate control animals. However, HER2/HER3 was not activated, and DNHER3 animals displayed fewer lung morphological changes at 10 and 21 days after injury ( P = 0.01). In addition, they contained 51% less collagen in injured lungs ( P = 0.04). Transforming growth factor-β1 did not increase in bronchoalveolar lavage fluid from DNHER3 mice compared with nontransgenic littermate mice ( P = 0.001), suggesting that a mechanism for the decreased fibrosis was lack of transforming growth factor-β1 induction in DNHER3 mice. Severe lung injury (0.08 units bleomycin) resulted in 80% mortality of nontransgenic mice, but only 35% mortality of DNHER3 transgenic mice ( P = 0.04). Thus inhibition of HER2/HER3 signaling protects against pulmonary fibrosis and improves survival.Keywords
This publication has 35 references indexed in Scilit:
- Conditional expression of transforming growth factor-α in adult mouse lung causes pulmonary fibrosisAmerican Journal of Physiology-Lung Cellular and Molecular Physiology, 2004
- Autocrine activation of ErbB2/ErbB3 receptor complex by NRG-1 in non-small cell lung cancer cell linesLung Cancer, 2004
- Expression and functional implications of CCR2 expression on murine alveolar epithelial cellsAmerican Journal of Physiology-Lung Cellular and Molecular Physiology, 2004
- Neuregulin-1 and ErbB4 Immunoreactivity Is Associated with Neuritic Plaques in Alzheimer Disease Brain and in a Transgenic Model of Alzheimer DiseaseJournal of Neuropathology & Experimental Neurology, 2003
- Time course of bleomycin‐induced lung fibrosisInternational Journal of Experimental Pathology, 2002
- The Catalytic Activity of the ErbB-2 Receptor Tyrosine Kinase Is Essential for Embryonic DevelopmentMolecular and Cellular Biology, 2002
- Bleomycin-induced pulmonary fibrosis in fibrinogen-null miceJournal of Clinical Investigation, 2000
- Binding specificities and affinities of egf domains for ErbB receptorsFEBS Letters, 1999
- Reversal of Lung Lesions in Transgenic Transforming Growth Factor α Mice by Expression of Mutant Epidermal Growth Factor ReceptorAmerican Journal of Respiratory Cell and Molecular Biology, 1996
- Cloning of the rat ErbB3 cDNA and characterization of the recombinant proteinGene, 1995